$ARX

RADKE JEFFREY L sold $965K of ARX (indirect holdings)

RADKE JEFFREY L (Co-Founder, CEO) sold 80,000 indirectly-held shares of Accelerant Holdings (ARX) at $12.06 ($0.96M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RADKE JEFFREY L
Published Aug 5, 2026, 12:18 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 1:36 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ARX
Neutral
high confidence
Mentioned
$ARX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARXNeutralLow
01

Why it matters

The disclosed event is a scheduled open-market sale by the CEO/co-founder under a 10b5-1 plan, with no accompanying fundamental or operational update.

02

Market read

Traders may briefly reassess sentiment around ARX due to insider selling, but the 10b5-1 framing makes it unlikely to drive a durable repricing.

03

What to watch

Indirect holdings and the presence of a 10b5-1 plan reduce interpretability; without additional context (e.g., multiple concurrent sales, changes in trading plans), the signal is weak.

Relevance 4/10Novelty 3/10Timing: Filed 2026-08-04 after sale dated 2026-08-03.

Background

The article is a SEC Form 4 insider transaction disclosure for Accelerant Holdings (ARX).

Company-level read

Ticker impact

$ARXNeutralHigh confidence
Context

Accelerant Holdings (ARX) disclosed a Form 4 showing co-founder/CEO Jeffrey L. Radke sold 80,000 shares at $12.0566 on a 10b5-1 plan.

Expected impact

Limited near-term impact; any effect is likely sentiment-driven and short-lived.

Evidence & confidence

The filing is a routine insider transaction with explicit 10b5-1 pre-arrangement, and it does not include new company fundamentals, guidance, or regulatory/legal developments.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is 10b5-1 pre-arranged, it may reflect scheduled liquidity needs rather than bearish expectations, so traders may overreact if they treat it as discretionary selling.

Key entities

  • Accelerant Holdings

    Company subject of the Form 4 insider transaction disclosure.

  • RADKE JEFFREY L

    Co-Founder, CEO, and 10% owner who executed the sale under a 10b5-1 plan.

Related articles

$ARXMed

ARX: Q2 2026 delivered robust operational and financial results, with the Shell acquisition progressing

Less than 1 min read Q2 2026 saw strong production growth and higher realized prices, driving a 20% year-over-year increase in funds from operations and a 94% rise in free funds flow per share. Net income declined 9% per share due to lower risk management gains and higher costs. The pending $22 billion Shell acquisition remains on track. Original document: ARC Resources Ltd. [ARX] Interim report — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies.

$ARXMed

ARX: Q2 2026 delivered robust production and cash flow as the $22B Shell acquisition advances

Less than 1 min read Q2 2026 saw 9% year-over-year production growth and strong cash flow, with $816 million in funds from operations and $349 million in free funds flow. The $22 billion Shell acquisition is progressing, with closing expected in Q3 2026. Original document: ARC Resources Ltd. [ARX] Earnings Release — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

$ARXMed

Accelerant Holdings Stock Rises 10%

Accelerant Holdings (ARX) shares rose 9.73% to $12.86 on Wednesday after the company said it expanded a partnership with Incline P&C Group. Effective July 1, 2026, Incline will act as a fronting carrier for over $500 million in annual gross written premiums across Accelerant’s U.S. commercial specialty insurance portfolio.

$ARXMedAI 8/10

Oil Volatility Is Back: 3 Canadian Stocks to Buy Now

The article says oil and gas prices remain volatile and highlights three Canadian energy stocks. Tourmaline Oil (TOU) reported record Q1 production and expects higher free cash flow in 2026-27, planning a $0.50 quarterly base dividend (yield ~3.1%). Birchcliff (BIR) reported strong Q1 2026 results and a $0.03 quarterly dividend. ARC Resources (ARX) reported Q1 2026 net income of $584m ($1.03/share) and agreed to be acquired by Shell in a ~$16.4bn deal including debt.